NEW YORK (GenomeWeb) – Bioinformatics firm N-of-One today announced an agreement with NeoGenomics to interpret the results of tests performed by the cancer genetics diagnostics firm.

Under the agreement, Lexington, Mass.-based N-of-One will provide clinical and interpretive evidence for NeoGenomics' NeoType solid tumor NGS tests, which report the most common and actionable genomic abnormalities in various subtypes of solid tumors.

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.